Posted: February 2018 Giorgio Vittorio Scagliotti, MD, Professor of Oncology at University of Torino and Head of the Department of Oncology and Chief of the Division of Medical Oncology at […] Read more
Posted: February 2018 During the past few years, improvements in the knowledge of immune system biology have dramatically changed the therapeutic paradigm for NSCLC. Pembrolizumab has been recently approved by […] Read more
John V. Heymach, MD, PhD
Posted: February 2018 John V. Heymach, MD, PhD, has been named a Fellow (Medical Sciences) of the American Association for the Advancement of Science (AAAS). Dr. Heymach is the Chair […] Read more
Tony S. K. Mok, BMSc, MD
Posted: February 2018 Tony S. K. Mok, BMSc, MD, has been elected to an International Oncologist seat of the 2019-2020 ASCO Board of Directors. Dr. Mok is the Li Shu […] Read more
5th AACR-IASLC International Joint Conference: Translational Progress through Basic Research
By Monte M. Winslow, PhD Posted: February 2018 Over 4 rainy days in San Diego, California, more than 220 participants from 15 different countries heard presentations that spanned a very […] Read more
Availability of next-generation sequencing continues to improve, but current technology cannot speed turnaround time of results. Posted: February 2018 The standard of care for all patients diagnosed with advanced nonsquamous […] Read more
An American Perspective on the European Lung Cancer Screening Implementation Plans
International sharing of best practices may improve quantitative imaging quality for low-dose CT for small nodules. By James L. Mulshine, MD Posted: February 2018 It is heartening to learn of […] Read more
New collaborative meeting to provide educational, scientific updates to diverse audience from Africa and the Middle East. By Joy Curzio, ILCN Managing Editor Posted: February 2018 As a global association, […] Read more
By Beth Eaby-Sandy, MSN, CRNP Posted: February 2018 When I started in thoracic medical oncology 15 years ago, we just had chemotherapy, and patient education was focused and streamlined. Chemotherapy […] Read more
By AnnMarie Estrada, IASLC Foundation Director Posted: February 2018 When you think of the IASLC, you think about professional development, networking, and renowned international lung cancer conferences. When you consider […] Read more